To evaluate the efficacy of Eranda taila Matrabasti with Tamsulosin tablet in the management of vatashtheela (mutraghata) w.s.r to benign prostatic hyperplasia.
- Conditions
- Benign prostatic hyperplasia withlower urinary tract symptoms. Ayurveda Condition: VATASHTHILA,
- Registration Number
- CTRI/2025/05/086983
- Lead Sponsor
- Matoshri Asarabai Darade Ayurved College,Babhulgaon,Yeola
- Brief Summary
Acharya Sushruta The father of indian surgery has described 12 types of Mutraghata in uttartantra and also described the management of mutraghata which includes Basti,Uttarbasti,Virechan etc. Chikitsa.
As ayurveda is an ancient science of medicine, had explained about the disease of urinary tract system i.e Mutraghata srotas under the topic of Mutrakricchara,Mutraghata, ashmari.
Acharya Charaka has explained, an Apan Vayu is situated in the space between rectum and urinary bladder which produced a hard swelling like a stone,which is mobile,elevated ,and glandular . Which obstruct the passage of urine and feaces and produce symptoms like sanga.
Prostate gland is the part of male reproductive system, it is of walnut size and weight about 1 ounce i.e 24 grams.Prostate is present below the urinary bladder and infront of rectum. it goes around the tube called urethra which carries urine from bladder out through penis.
BPH is enlargement of medial lobe of prostate is responsible for obstruction of urethra. This lobe upwards into the bladder.
Medicines like ALPHA BLOCKERS i.e Tamsulosin is effective in benign prostatic hyperplasia. Tamsulosin works by relaxing the muscle around the bladder and prostate gland so urine is passed more easily. This helps empty the bladder completely and reduces the need to pass urine frequently or urgently in BPH.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Male
- Target Recruitment
- 64
- 1.Age group between 40 yrs to 70 yrs.
- 2.Classical sign and symptoms of Mutraghata (BPH).
- 3.USG of prostate suggestive of increased size and weight.
- 4.Significant post voidal urine of greater than 90CC upto 200 CC.
- 1.Age below 40 yrs and above 70 yrs.
- 2.Acute retention of urine.
- 3.Severe urinary calculi with significant obstructive uropathy.
- 5.Renal failure.
- 6.Systemic diseases like HIV, Hepatitis, T2DM.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 6.Straining 1st,14th,21st,28th The patient will be diagnosed based on symptoms of Vatashteela (Mutraghata) explained in Ayurvdic and Modern texts. 1st,14th,21st,28th 5.Weak Stream 1st,14th,21st,28th 2.Frequency 1st,14th,21st,28th 1.Incomplete Emptying 1st,14th,21st,28th 3.Intermittency 1st,14th,21st,28th The parameters will be noted down before and after treatment. 1st,14th,21st,28th 4.Urgency 1st,14th,21st,28th 7.Nocturia 1st,14th,21st,28th
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Matoshri Asarabai Darade Hospital,Babhulgaon,Yeola
🇮🇳Nashik, MAHARASHTRA, India
Matoshri Asarabai Darade Hospital,Babhulgaon,Yeola🇮🇳Nashik, MAHARASHTRA, IndiaDr Kiran Uttam SirsatPrincipal investigator07385349279sirsat230@gmail.com